AGCO
AGCO
$104.47
+1.15%
AGCO Corporation is a global manufacturer of agricultural machinery, producing tractors, combines, hay tools, and precision-agriculture technology under flagship brands Fendt, Massey Ferguson, and Valtra, with its digital and precision-ag portfolio consolidated under the PTx umbrella. The company occupies a top-tier position in the global ag-equipment oligopoly alongside Deere and CNH, distinguished by an unusually heavy European/Middle East sales skew (50-60% of revenue and an even larger share of operating profit) and a distribution network spanning 3,000-plus dealers in over 140 countries. The current investor narrative centers on a multi-year downcycle in global farm equipment demand, with the most recent quarter showing a slight year-over-year revenue decline and a sharp compression in net income versus the prior-year period, even as management leans on cost discipline, share buybacks, and PTx precision-ag investments to defend margins. Debate is intensifying around whether the cycle is bottoming — reflected in the stock's sharp August-to-September rally and subsequent October give-back — and whether AGCO's European profit concentration is an asset or a vulnerability given soft EU farm incomes and elevated used-inventory levels.…
AGCO
AGCO
$104.47
Investment Opinion: Should I buy AGCO Today?
Synthesized recommendation: Hold. AGCO presents a classic value trap vs. deep-value opportunity debate. The analyst consensus is 'buy' with a mean rating of 2.44 and an average target price of $125.87, implying 21.9% upside, but the wide target range ($98-$151) and mixed institutional posture (one upgrade, one Underweight, several neutrals) suggest caution. The core thesis is that the stock is deeply discounted on sales and book value, but earnings are collapsing, and the downcycle may not be over.
Supporting evidence for a Hold: (1) Valuation is undemanding at 0.77x PS and 1.82x PB, far below historical norms, and 9.62x EV/EBITDA is cheap vs. peers. (2) Revenue growth is negative (-0.96% YoY) and decelerating sequentially, with Q2 2026 revenue down 10.6% from Q4 2025. (3) Profitability has compressed sharply: net margin fell to 2.96% in Q2 2026 from 11.95% a year earlier, and operating margin is just 5.82%. (4) Free cash flow is positive at $330.3 million trailing, but highly seasonal and working-capital dependent. (5) The implied upside to the average analyst target is 21.9%, but the low target of $98 is only 5% below the current price, limiting downside protection.
The biggest risks that could invalidate the thesis are: (1) A deeper-than-expected downturn in European farm equipment demand, which would further pressure revenue and margins. (2) Continued earnings estimate cuts, which would make the forward PE of 13.86x look expensive. (3) A break below the 52-week low of $98.22, which could trigger technical selling. The rating would upgrade to Buy if revenue growth turns positive and operating margins stabilize above 7%, or if the stock falls below $95 with no fundamental deterioration. It would downgrade to Sell if revenue declines accelerate beyond -5% YoY or if operating margins fall below 4%. Relative to its own history and peers, AGCO appears undervalued, but the market is pricing in a prolonged downturn, and until there is evidence of a cycle bottom, the stock is likely to remain range-bound.
Sign up to view all
AGCO 12-Month Price Forecast
AGCO is a deeply cyclical stock in the trough of a downcycle, with earnings collapsing but valuation already pricing in a severe downturn. The risk/reward is balanced: the stock could rally 22% to the average analyst target if the cycle turns, but it could also break below $98 if conditions worsen. The neutral stance reflects this uncertainty. I would upgrade to bullish if Q3 2026 results show revenue growth and margin stabilization, and downgrade to bearish if revenue declines accelerate or margins fall below 4%.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on AGCO's 12-month outlook, with a consensus price target around $125.87 and implied upside of +20.5% versus the current price.
Average Target
$125.87
0 analysts
Implied Upside
+20.5%
vs. current price
Analyst Count
—
covering this stock
Price Range
$98 - $151
Analyst target range
Coverage is solid, with 15 analysts following AGCO, and the consensus recommendation is "buy" with a recommendation mean of 2.44 (where lower is more bullish on a 1-5 scale). The average target price is $125.87, which implies roughly +21.9% upside from the current $103.28, and the consensus 2026 EPS estimate of $8.90 against the current price implies a forward multiple near 11.6x — undemanding if the estimate holds. Sentiment is therefore moderately bullish, but the "buy" label masks a wide dispersion of views: recent actions include Baird upgrading to Outperform from Neutral on August 31, 2026, while Morgan Stanley maintained an Underweight rating on August 4, 2026, and UBS, Citigroup, and Wells Fargo all stayed Neutral/Equal Weight. The target range runs from a low of $98.00 to a high of $151.00 — a spread of $53, or roughly 54% of the low target — which signals unusually high uncertainty about the cycle's depth and timing. The high target of $151 implies a recovery in farm equipment demand, multiple expansion back toward historical norms, and successful PTx monetization; the low target of $98 essentially prices in a continued downcycle with margin compression and no earnings recovery, sitting just below the 52-week low of $98.22. The wide spread, combined with the stock trading near the bottom of its range and the mixed institutional posture (one upgrade, one Underweight reiteration, several neutrals), suggests the market is waiting for evidence of a demand inflection before re-rating the shares — a setup that offers asymmetric upside if the cycle turns but meaningful downside if the trough proves deeper than consensus assumes.
Bulls vs Bears: AGCO Investment Factors
The bear case currently has stronger evidence, primarily because AGCO's earnings have collapsed 75% year-over-year and revenue is stagnating, with no clear sign of a demand inflection. The technical picture is also bearish, with the stock near its 52-week low and massively underperforming the market. However, the bull case rests on deep value metrics (0.77x PS, 1.82x PB) that are far below historical norms, a conservative balance sheet, and a consensus analyst target implying 22% upside. The single most important tension is whether the agricultural equipment downcycle is bottoming or has further to run; if Q3 or Q4 2026 results show stabilizing orders and margins, the stock could re-rate sharply, but if the trough deepens, the low target of $98 and potential break below the 52-week low become realistic.
Bullish
- Deep value on sales and book: AGCO trades at just 0.77x trailing sales and 1.82x book value, far below its historical PS range of roughly 2.2x-4.1x and near the low end of its multi-year 1.76x-2.96x PB band. The 9.62x EV/EBITDA and 10.69x trailing PE are also well below the mid-teens-to-low-twenties earnings multiple typical of agricultural machinery peers, implying a 30-50% discount on earnings and 50%+ on sales. This suggests the market is pricing in a severe, durable downturn rather than a structural impairment.
- Analyst consensus sees 22% upside: With 15 analysts covering the stock, the consensus recommendation is 'buy' (mean 2.44) and the average target price of $125.87 implies roughly +21.9% upside from the current $103.28. The high target of $151.00 suggests a recovery scenario where farm equipment demand rebounds, multiples expand, and PTx precision-ag monetization succeeds. Even the low target of $98.00 is only about 5% below the current price, creating an asymmetric risk/reward skew.
- Balance sheet remains conservative: Debt-to-equity is a low 0.63, the current ratio is a healthy 1.39, and trailing free cash flow is $330.3 million. The company returned $347 million via buybacks and $21 million in dividends in Q2 2026 alone, demonstrating strong capital return capacity even during a downcycle. ROE of 17.0% and ROA of 3.47% indicate reasonable capital efficiency despite the earnings trough.
- Parts and PTx offer margin cushion: Replacement parts revenue of $516.2 million in Q2 2026 provides a high-margin, recurring revenue stream that helps offset falling new-equipment volumes. The PTx precision-ag portfolio, built through acquisitions, represents a potential growth catalyst as adoption increases, and management is leaning on cost discipline to defend margins. Gross margin actually expanded slightly to 24.75% in Q2 2026 from 24.35% a year earlier, showing pricing power and mix benefits.
Bearish
- Earnings collapsed 75% year-over-year: Q2 2026 net income was just $77.2 million, down roughly 75% from $314.8 million in Q2 2025, despite revenue only falling 0.96% to $2.61 billion. The damage is coming from below the gross-profit line: SG&A of $335.7 million, R&D of $141.2 million, and $17 million of interest expense compressed operating margin to 5.82% from 7.49%. This severe operating deleverage shows how thin the earnings base is and how sensitive it is to volume declines.
- Revenue stagnating, down sequentially: Q2 2026 revenue of $2.61 billion was down 0.96% year-over-year and down 10.6% sequentially from Q4 2025's $2.92 billion. The pattern of sequential decline points to weakening end-market demand rather than seasonal noise, and the -0.96% YoY print suggests that replacement demand and PTx adoption are not yet sufficient to offset falling new-equipment volumes. With global farm incomes under pressure, especially in Europe, the revenue trajectory could deteriorate further.
- Forward PE above trailing signals falling estimates: The trailing PE of 10.69x is below the forward PE of 13.86x, which implies the market expects earnings to decline over the next twelve months. The consensus EPS estimate of $8.90 versus trailing EPS of $0.09 is noisy, but the forward multiple near 11.6x on that estimate is only undemanding if the estimate holds. Any downward revision to 2026 EPS would make the stock look more expensive on a forward basis.
- Heavy European exposure is a vulnerability: AGCO derives 50-60% of sales and an even larger share of operating profits from Europe/Middle East, where soft farm incomes and elevated used-inventory levels are pressuring demand. This concentration makes the company more sensitive to European agricultural policy, weather, and economic conditions than peers with more balanced geographic footprints. The company's efforts to increase North and South American exposure have not yet materially reduced this risk.
AGCO Technical Analysis
AGCO is in a broad, choppy downtrend punctuated by violent counter-trend rallies. The stock is down 5.27% over the past year and 14.81% over six months, and at $103.28 it sits at roughly 11% of its 52-week range of $98.22-$143.78 — a deeply depressed positioning that signals persistent distribution rather than healthy consolidation. Trading this close to the 52-week low means the stock is either a value opportunity for contrarians or a falling knife, and the burden of proof sits with the bulls given the absence of a higher low. Recent momentum has deteriorated sharply: the 1-month change is -18.60% versus the S&P 500's +2.12%, producing a relative-strength reading of -20.72 percentage points, one of the worst divergences in the data set. The 3-month change of -9.66% and 6-month change of -14.81% confirm that the short-term weakness is not a one-off air pocket but the latest leg of a longer decay, and the October 9 close of $103.28 came on a -4.49% single-day drop that suggests capitulation-style selling rather than orderly profit-taking. Key support sits at the 52-week low of $98.22, roughly 4.9% below the current price; a decisive break there would likely open a new leg lower and validate the bearish trend. Resistance is anchored at the 52-week high of $143.78, but the more immediate hurdle is the $120-$127 zone where the September rally repeatedly failed. With a beta of 1.074, AGCO is only marginally more volatile than the market, so the -29.92% max drawdown reflects stock-specific deterioration rather than simple high-beta amplification — position sizing should account for the fact that this is a fundamentally challenged name, not merely a leveraged market proxy.
Beta
1.07
1.07x market volatility
Max Drawdown
-29.9%
Largest decline past year
52-Week Range
$98-$144
Price range past year
Annual Return
+0.7%
Cumulative gain past year
| Period | AGCO Return | S&P 500 |
|---|---|---|
| 1m | -13.7% | +1.8% |
| 3m | -8.5% | +3.5% |
| 6m | -9.4% | +11.2% |
| 1y | +0.7% | +19.1% |
| ytd | -1.3% | +14.1% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
AGCO Fundamental Analysis
AGCO's revenue trajectory is stagnating at a low level. Q2 2026 revenue was $2.61 billion, down 0.96% year over year from $2.635 billion, following Q1 2026 revenue of $2.343 billion and Q4 2025 revenue of $2.920 billion — a pattern of sequential decline that points to weakening end-market demand rather than seasonal noise. The segment mix shows tractors at $1.669 billion and replacement parts at $516.2 million, with parts providing a high-margin, recurring cushion, while the grain storage and protein production line is immaterial at $100,000. The investment case now hinges on whether replacement demand and PTx precision-ag adoption can offset falling new-equipment volumes; the -0.96% YoY print suggests the offset is not yet sufficient. Profitability has compressed materially. Q2 2026 net income was $77.2 million on a 24.75% gross margin and a 2.96% net margin, versus Q2 2025 net income of $314.8 million on a 24.35% gross margin — meaning the gross margin actually expanded slightly while net income fell roughly 75%, a clear signal that the damage is coming from below the gross-profit line, including SG&A of $335.7 million, R&D of $141.2 million, and $17 million of interest expense. Operating income fell to $151.9 million (5.82% operating margin) from $197.3 million (7.49%) a year earlier, and the Q1 2026 operating margin was even thinner at 3.96%. The company remains solidly profitable, but the earnings base is thin and highly sensitive to volume deleverage. The balance sheet is the strongest part of the story. Debt-to-equity is a conservative 0.63, the current ratio is 1.39, and trailing free cash flow is $330.3 million, though the quarterly cadence is lumpy — Q1 2026 FCF was -$455 million on a $521.3 million working-capital build, while Q2 2026 rebounded to +$108.2 million. ROE of 17.0% and ROA of 3.47% indicate reasonable capital efficiency despite the downcycle, and the company returned capital aggressively in Q2 2026 with $347 million of buybacks and $21 million of dividends. The main caveat is that cash generation is seasonal and working-capital dependent, so investors should watch inventory and receivables rather than extrapolate any single quarter.
Quarterly Revenue
$2.6B
2026-06
Revenue YoY Growth
-1.0%
YoY Comparison
Gross Margin
24.8%
Latest Quarter
Free Cash Flow
$330300000.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is AGCO Overvalued?
Because AGCO is profitable — trailing EPS of $0.09 and Q2 2026 net income of $77.2 million — the PE ratio is the appropriate primary metric, though the trailing figure is distorted by a depressed earnings base. The trailing PE of 10.69x versus a forward PE of 13.86x implies the market expects earnings to decline, not grow, over the next twelve months; normally a forward multiple above the trailing multiple signals falling estimates, and here the consensus EPS estimate of $8.90 versus the trailing figure underscores how noisy the trailing number is. On a price-to-sales basis, the 0.77x PS ratio and 0.98x EV/Sales are undemanding in absolute terms. Relative to the broader Industrials/Agricultural Machinery peer set, AGCO screens cheap: a 10.69x trailing PE and 0.77x PS sit below the sector's typical mid-teens-to-low-twenties earnings multiple and roughly 1.5x-2.0x sales range, implying a discount of roughly 30-50% on earnings and 50%+ on sales. The discount is partly justified by AGCO's below-peer growth (revenue -0.96% YoY), thin 6.93% operating margin, and heavy European exposure, but the 9.62x EV/EBITDA and 1.82x price-to-book suggest the market is pricing in a prolonged downturn rather than a structural impairment. Historically, AGCO's own PE has ranged from roughly 6x at cycle troughs (Q3 2025, Q2 2025) to over 100x during earnings-depressed periods (Q1 2025), and its PS ratio has ranged from about 2.2x to 4.1x over the past several years; the current 0.77x PS is far below that entire historical band, which is a striking signal. Either the market is pricing in a severe, durable earnings reset, or the stock is mispriced relative to its own history — the 1.82x PB, near the low end of its multi-year 1.76x-2.96x range, tilts the evidence toward the former being overdone, though the negative PEG ratio of -0.04 reflects the current earnings trough and offers no support.
PE
10.7x
Latest Quarter
vs. Historical
Low-End
5-Year PE Range 6x~28x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
9.6x
Enterprise Value Multiple
Investment Risk Disclosure
AGCO's financial and operational risks are significant. The most acute risk is earnings volatility: Q2 2026 net income fell 75% year-over-year to $77.2 million despite only a 0.96% revenue decline, highlighting severe operating deleverage. With operating margins at just 5.82% in Q2 2026 and 3.96% in Q1 2026, the company has little buffer if volumes decline further. Revenue is concentrated in Europe/Middle East (50-60% of sales and even more of operating profit), exposing the company to regional farm income weakness and elevated used-inventory levels. Additionally, free cash flow is lumpy and working-capital dependent: Q1 2026 FCF was -$455 million on a $521.3 million working-capital build, while Q2 2026 rebounded to +$108.2 million, making cash generation unpredictable.
Market and competitive risks are also material. AGCO trades at a discount to peers (10.69x trailing PE vs. sector mid-teens-to-low-twenties), but this discount could persist or widen if the downcycle proves deeper than expected. The forward PE of 13.86x is above the trailing PE, indicating the market expects earnings to decline, and any further estimate cuts could pressure the multiple. The company faces intense competition from Deere and CNH, who have greater scale and North American exposure. With a beta of 1.074, AGCO is only marginally more volatile than the market, but its -29.92% max drawdown reflects stock-specific deterioration rather than high-beta amplification. Sector rotation away from Industrials could also weigh on the shares.
The worst-case scenario would be a prolonged global farm recession, particularly in Europe, leading to further volume declines and margin compression. If AGCO's revenue falls another 5-10% and operating margins contract to 3-4%, earnings could approach zero, and the stock could test its 52-week low of $98.22, representing a 4.9% decline from the current price. A break below that level could trigger a new leg down toward the analyst low target of $98.00, and in a severe scenario, the stock could fall to the $80-$90 range, implying a 13-23% loss from current levels. The max drawdown of -29.92% over the past year shows the stock is capable of such declines.
FAQ
The key risks are: (1) Earnings volatility – net income fell 75% year-over-year in Q2 2026 despite a less than 1% revenue decline, showing severe operating deleverage. (2) Geographic concentration – 50-60% of sales and even more of operating profit come from Europe/Middle East, where farm incomes are weak and used-inventory levels are high. (3) Cyclical downturn – the global farm equipment market is in a downcycle, and a deeper or longer downturn could push earnings to zero and the stock below $98. (4) Competitive pressure – Deere and CNH have greater scale and North American exposure, potentially leading to market share loss. (5) Technical weakness – the stock is near its 52-week low and in a downtrend, with no higher low established.
Our 12-month forecast has three scenarios: Bull case (25% probability) with a target range of $140-$151, driven by a demand recovery and margin expansion; Base case (50% probability) with a target range of $115-$130, assuming a slow recovery and stable margins; Bear case (25% probability) with a target range of $85-$98, if the downcycle deepens and earnings estimates are cut. The base case is most likely, implying a return to the average analyst target of $125.87, or about 22% upside. The key assumption is that global farm equipment demand stabilizes and operating margins improve modestly to 6-7%.
AGCO appears undervalued relative to its own history and peers. The trailing PE of 10.69x and forward PE of 13.86x are below the sector's typical mid-teens-to-low-twenties multiple, and the PS ratio of 0.77x is far below its historical range of 2.2x-4.1x. The EV/EBITDA of 9.62x and PB of 1.82x are also at the low end of historical ranges. However, the discount is partly justified by AGCO's negative revenue growth (-0.96% YoY), thin operating margin (5.82%), and heavy European exposure. The market is pricing in a prolonged downturn; if the cycle turns, the stock could re-rate significantly, but if the downturn deepens, the discount could persist.
AGCO is a good buy only for investors with a high risk tolerance and a long-term horizon who believe the agricultural equipment downcycle is nearing a bottom. The stock trades at a deep discount to historical norms (0.77x PS vs. 2.2x-4.1x historically) and offers 21.9% upside to the average analyst target of $125.87. However, earnings have collapsed 75% year-over-year, and revenue is declining, so the timing of a recovery is uncertain. The low analyst target of $98 is only 5% below the current price, limiting downside, but a break below the 52-week low of $98.22 could trigger further losses. For value investors with patience, the risk/reward is favorable, but for short-term traders, the stock is a falling knife.
AGCO is more suitable for long-term investment than short-term trading. The stock is in a cyclical downturn, and the timing of a recovery is uncertain, so short-term traders face significant volatility and headline risk. The beta of 1.074 indicates moderate volatility, but the -29.92% max drawdown over the past year shows the potential for sharp declines. The dividend yield of 1.11% is modest, so income is not a primary attraction. For long-term investors, the deep valuation discount and strong balance sheet offer a margin of safety, and the PTx precision-ag investments could drive growth in the next upcycle. A minimum holding period of 2-3 years is suggested to ride out the cycle.